Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2PIRTOBRUTINIB

02 10SELPERCATINIB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : JAYPIRCA

2024 ACI Convention
Not Confirmed
arrow

Brand Name : JAYPIRCA

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : TABLET;ORAL

Brand Name : JAYPIRCA

Dosage Strength : 50MG

Packaging :

Approval Date : 2023-01-27

Application Number : 216059

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : JAYPIRCA

2024 ACI Convention
Not Confirmed
arrow

Brand Name : JAYPIRCA

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : TABLET;ORAL

Brand Name : JAYPIRCA

Dosage Strength : 100MG

Packaging :

Approval Date : 2023-01-27

Application Number : 216059

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : RETEVMO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : RETEVMO

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : CAPSULE;ORAL

Brand Name : RETEVMO

Dosage Strength : 40MG

Packaging :

Approval Date : 2020-05-08

Application Number : 213246

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : RETEVMO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : RETEVMO

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : TABLET;ORAL

Brand Name : RETEVMO

Dosage Strength : 40MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : RETEVMO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : RETEVMO

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : TABLET;ORAL

Brand Name : RETEVMO

Dosage Strength : 80MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

06

Brand Name : RETEVMO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : RETEVMO

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : TABLET;ORAL

Brand Name : RETEVMO

Dosage Strength : 160MG

Packaging :

Approval Date : 2024-04-10

Application Number : 218160

Regulatory Info : RX

Registration Country : USA

blank

07

Brand Name : RETEVMO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : RETEVMO

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : CAPSULE;ORAL

Brand Name : RETEVMO

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 218160

Regulatory Info :

Registration Country : USA

blank

08

Brand Name : RETEVMO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : RETEVMO

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : CAPSULE;ORAL

Brand Name : RETEVMO

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number : 218160

Regulatory Info :

Registration Country : USA

blank

09

Brand Name : RETEVMO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : RETEVMO

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : CAPSULE

Brand Name : RETEVMO

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2516918

Regulatory Info : Prescription

Registration Country : Canada

blank

10

Brand Name : RETEVMO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : RETEVMO

arrow
2024 ACI Convention
Not Confirmed

Loxo Oncology Inc

Dosage Form : CAPSULE

Brand Name : RETEVMO

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number : 2516926

Regulatory Info : Prescription

Registration Country : Canada

blank